HIPGEN | Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial
01-01-2018
-30-09-2022
01-01-2018
-30-09-2022
01-01-2017
-31-12-2021
01-10-2017
-31-03-2022
01-03-2019
-31-07-2020
01-01-2023
-31-12-2027